Comments
Celgene to appeal negative European opinion on Istodax
21.07.2012. | (Reuters) - Celgene Corp said on Friday it plans to ask a European advisory panel to reconsider its decision not to recommend approval of the company's treatment for relapsed or refractory peripheral t-cell lymphoma (PTCL)....
